The story
In 1937 the South African-born virologist Max Theiler and his colleagues at the Rockefeller Foundation in New York announced the 17D yellow fever vaccine, a weakened strain of the virus that gives long-lasting protection. Yellow fever, spread by mosquitoes, causes fever, jaundice and bleeding, and had ravaged tropical ports and armies. Theiler's team took a strain called Asibi, after the Ghanaian man from whom it was isolated in 1927, and passed it repeatedly through mouse and chick embryo tissue, more than a hundred times. The virus gradually lost its ability to cause severe disease while still stimulating immunity. The result, strain 17D, was safe for people.
In 1900 and 1901 Walter Reed's commission in Cuba confirmed that the Aedes aegypti mosquito carries yellow fever and that a tiny agent, smaller than bacteria, caused it, a finding that helped found the study of viruses. Vaccination soon began in tropical Africa and the Americas, and the Rockefeller laboratories shipped millions of doses. During World War II the U.S. military vaccinated its troops, and in 1942 some batches stabilized with human serum caused an outbreak of hepatitis among soldiers, after which the serum was dropped. Theiler received the 1951 Nobel Prize in Physiology or Medicine. The 17D vaccine is still used, and the World Health Organization says one dose gives lifelong protection.
Why it mattered
- Mass vaccination controlled yellow fever across tropical Africa and South America and protected travelers and troops.
- The use of viruses weakened by repeated passage became a model for later live vaccines.
- Growing viruses in chick embryos became standard in vaccine production, as in the later influenza vaccines.
- Theiler's Nobel Prize recognized virus vaccines as a central part of modern medicine.
Sources
- Max Theiler, Nobel Lecture (the 17D vaccine) Nobel Prize
- The long road to the yellow fever vaccine Rockefeller Archive Center
- Theiler, Max (1899-1972) Encyclopedia.com
- Controlling Disease during World War II, 1939-1944 National Library of Medicine
- Yellow fever vaccine booster doses (2013 WHO SAGE conclusion) NITAG Resource Centre
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…